What is Wound Healing Technologies?
Wound Healing Technologies (WHT) operates at the intersection of medical device innovation and clinical efficiency. The company is best known for its Tzoar 207 Negative Pressure Wound Therapy (NPWT) system, a solution engineered to streamline complex wound management in high-volume nursing environments. By offering an all-inclusive daily rental model, WHT effectively removes the logistical and financial barriers typically associated with advanced wound care. This service-oriented approach, which integrates 24/7 clinical support and comprehensive staff training, allows healthcare providers to maintain high standards of patient outcomes while optimizing operational workflows. Their decade-long track record underscores a commitment to reducing the burden on nursing staff through reliable, accessible technology.
How much funding has Wound Healing Technologies raised?
Wound Healing Technologies has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Wound Healing Technologies
PPP
Public-Private Partnership
What's next for Wound Healing Technologies?
With this late-stage capital, Wound Healing Technologies is positioned to scale its operational footprint and deepen its penetration within the domestic healthcare market. The strategic focus will likely shift toward expanding the distribution of the Tzoar 207 system and enhancing the digital integration of their clinical support services. As the demand for efficient, outsourced medical solutions in nursing homes continues to rise, WHT is well-equipped to leverage its current backing to solidify its role as a primary provider of wound care infrastructure. Future initiatives may include the development of next-generation therapy modules and the expansion of their dedicated support teams to meet the evolving needs of the aging population.
See full Wound Healing Technologies company page
